{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:30:20Z","timestamp":1793320220491,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/iop.0000000000000037","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T04:26:51Z","timestamp":1391660811000},"page":"162-167","source":"Crossref","is-referenced-by-count":176,"title":["Treatment of Active Corticosteroid-Resistant Graves\u2019 Orbitopathy"],"prefix":"10.1097","volume":"30","author":[{"given":"Jose Vicente","family":"P\u00e9rez-Moreiras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"\u00c1lvarez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estanislao Cardiel","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/thy.2007.0404","article-title":"Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.","volume":"18","author":"Smith","year":"2008","journal-title":"Thyroid"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2249.2006.03316.x","article-title":"Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes.","volume":"148","author":"Douglas","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"R3-14-20210129","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves ophthalmopathy.","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.4049\/jimmunol.181.8.5768","article-title":"B cells from patients with Graves disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.","volume":"181","author":"Douglas","year":"2008","journal-title":"J Immunol"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/IOP.0b013e318179f8a5","article-title":"Novel immunomodulating agents for Graves orbitopathy.","volume":"24","author":"Bartalena","year":"2008","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves orbitopathy.","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ophtha.2007.10.028","article-title":"Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.","volume":"115","author":"Bradley","year":"2008","journal-title":"Ophthalmology"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNO.0b013e31814a5ef8","article-title":"Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.","volume":"27","author":"Zoumalan","year":"2007","journal-title":"J Neuroophthalmol"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves ophthalmopathy.","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/IOP.0b013e3181c4dfde","article-title":"Rituximab for thyroid eye disease.","volume":"26","author":"Silkiss","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"HERMES Trial Group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(03)00032-4","article-title":"B-cell depletion with rituximab-a targeted therapy for Graves disease and autoimmune thyroiditis.","volume":"88","author":"Hasselbalch","year":"2003","journal-title":"Immunol Lett"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","article-title":"Treatment of Graves disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.","volume":"156","author":"Salvi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R16-14-20210129","first-page":"1","article-title":"Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.","volume":"117","author":"Chong","year":"2010","journal-title":"Ophthalmology"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/thy.2007.0407","article-title":"Immune mechanisms in thyroid eye disease.","volume":"18","author":"Lehmann","year":"2008","journal-title":"Thyroid"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/105072501753210984","article-title":"Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves ophthalmopathy.","volume":"11","author":"Jyonouchi","year":"2001","journal-title":"Thyroid"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis.","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis.","volume":"2","author":"Smolen","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14728222.11.5.613","article-title":"The IL-6sIL-6R complex as a novel target for therapeutic approaches.","volume":"11","author":"Rose-John","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2040622312466908","article-title":"Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy.","volume":"4","author":"Kaneko","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves ophthalmopathy.","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7015-11-88","article-title":"Biologic therapy for autoimmune diseases: an update.","volume":"11","author":"Rosman","year":"2013","journal-title":"BMC Med"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/07435800.2011.635622","article-title":"CD8CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves orbitopathy and correlate with disease activity.","volume":"37","author":"Slowik","year":"2012","journal-title":"Endocr Res"},{"key":"R26-14-20210129","first-page":"317","article-title":"Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.","volume":"151","author":"Smith","year":"1997","journal-title":"Am J Pathol"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves disease and ophthalmopathy.","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr Rev"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0000000000000037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:13:39Z","timestamp":1620940419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201403000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0000000000000037","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718269210.793492867","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718269210.793541926","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718269210.793494386","asserted-by":"object"}]},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}